BIOMAT Database Logo BIOMAT Database Logo

[Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients]. 1986

Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun

The effect of intracoronary streptokinase administration (31 patients), verapamil treatment (23 patients) and conventional therapy (27 patients) on the size of the affected area was examined in patients with acute myocardial infarction (MI). Streptokinase was administered in a dose of 250,000-500,000 IU within the first 3 to 20 hours of myocardial infarction, and verapamil, 360 to 400 mg, daily within the first 5 to 12 hours of the attack. The occluded coronary artery was recanalized in response to streptokinase administration in 21 patients. Serial measurements of CPK activity and serum myoglobin levels, and electrocardiographic precordial cartograms demonstrated a reduction in MI size following streptokinase administration. Verapamil had no basic effect on the final size of myocardial lesion, although it improved somewhat the clinical course of the disease.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
[Intracoronary streptokinase in acute myocardial infarct].
December 1981, Deutsche medizinische Wochenschrift (1946),
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
[Limitation of the size of the myocardial infarct by using intracoronary streptokinase administration].
January 1982, Terapevticheskii arkhiv,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Intracoronary streptokinase infusion in patients with acute myocardial infarction.
December 1984, Missouri medicine,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
[Intracoronary streptokinase in acute myocardial infarct. Experience with 461 patients].
April 1985, Deutsche medizinische Wochenschrift (1946),
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
September 2018, Circulation research,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Thrombolysis in acute myocardial infarction: effect of intravenous followed by intracoronary streptokinase application on estimates of infarct size.
June 1984, The American journal of cardiology,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Treatment of acute myocardial infarction with intracoronary infusion of streptokinase.
July 1982, IMJ. Illinois medical journal,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
[Overall assessment of the results of intravenous and intracoronary infusion of streptokinase in acute myocardial infarct].
January 1984, Vutreshni bolesti,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Verapamil and myocardial infarct size.
August 1980, The American journal of cardiology,
Ia S Vasil'tsev, and R S Karpov, and V A Markov, and V I Varvarenko, and V I Kun
Systemic versus intracoronary streptokinase infusion in the treatment of acute myocardial infarction.
May 1983, Journal of the American College of Cardiology,
Copied contents to your clipboard!